Global Information
회사소개 | 문의 | 비교리스트

세계 및 중국의 신약 재창출(Drug Repositioning) 시장 규모, 상황 및 예측(2020-2027년)

Global and China Drug Repositioning Market Size, Status and Forecast 2020-2027

리서치사 QYResearch
발행일 2021년 05월 상품코드 1006742
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 3,900 ₩ 5,638,000 PDF (Single User License)
US $ 5,850 ₩ 8,457,000 PDF (Multi User License)
US $ 7,800 ₩ 11,277,000 PDF (Enterprise User License)


세계 및 중국의 신약 재창출(Drug Repositioning) 시장 규모, 상황 및 예측(2020-2027년) Global and China Drug Repositioning Market Size, Status and Forecast 2020-2027
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 신약 재창출(Drug Repositioning) 시장 규모는 2020년에 249억 5,800만 달러에 달했습니다.

시장은 2021-2027년간 4.7%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2027년에는 346억 200만 달러에 달할 것으로 예측됩니다. 중국 시장 규모는 예측기간 중 6.86%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 17억 6,900만 달러에서 2027년에는 28억 4,300만 달러에 달할 것으로 예측됩니다.

세계 및 중국의 신약 재창출(Drug Repositioning)(Drug Repositioning) 시장에 대해 조사했으며, 시장 규모와 예측, 동향, 성장요인 및 과제, 종류·용도·기업·지역(국가)별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 보고서 개요

  • 조사 범위
  • 유형별 시장 분석
    • 유형별 : 세계의 신약 재창출(Drug Repositioning) 시장 규모 성장률(2020년 vs. 2027년)
    • 제네릭 의약품
    • 임상시험에서 실패한 의약품
  • 용도별 시장
    • 용도별 : 세계의 신약 재창출(Drug Repositioning) 시장 점유율(2020년 vs. 2027년)
    • 심혈관질환
    • 정신질환
  • 조사 목적 조사 대상년도

제2장 세계의 성장 동향

  • 세계 시장 전망(2015-2027년)
  • 지역별 : 성장 동향
    • 지역별 : 시장 규모(2015년 vs. 2020년 vs. 2027년)
    • 지역별 : 시장 규모(2015-2020년)
    • 지역별 : 시장 규모 예측(2021-2027년)
    • 중국의 세계 시장 점유율(2015-2027년)
  • 업계 동향과 성장 전략
    • 시장의 주요 동향
    • 시장 성장 촉진요인
    • 시장이 해결해야 할 과제
    • Porter의 산업 분석

제3장 기업별 : 경쟁 구도

  • 시장 규모별 : 세계 주요 기업
    • 매출별 : 세계의 주요 기업(2019-2020년)
    • 기업별 : 세계 시장 매출 점유율(2019-2020년)
    • 조사 대상 기업 매출 기준 순위
    • 기업 유형별 : Tier 1, Tier 2, Tier 3
  • 세계 시장 집중률
    • 세계 시장 집중도(CR5 및 HHI)
    • 2019년 매출별 : 세계 주요 기업 3개사/5개사
  • 주요 기업의 본사와 서비스 제공 지역
  • 주요 기업의 제품 솔루션과 서비스
  • 제조업체 설립일
  • 인수합병(M&A) 및 확장 계획

제4장 유형별 : 분석 데이터

  • 유형별 : 시장 규모(2015-2020년)
  • 유형별 : 시장 규모 예측(2021-2027년)

제5장 용도별 : 분석 데이터

  • 용도별 : 시장 규모(2015-2020년)
  • 용도별 : 시장 규모 예측(2021-2027년)

제6장 북미

  • 북미 시장 규모의 전년대비 성장률(2015-2027년)
  • 북미의 주요 기업(2019-2020년)
  • 북미 시장 : 유형별(2015-2020년)
  • 북미 시장 규모 : 용도별(2015-2020년)

제7장 유럽

  • 유럽 시장 규모의 전년대비 성장률(2015-2027년)
  • 유럽의 주요 기업(2019-2020년)
  • 유럽 시장 : 유형별(2015-2020년)
  • 유럽 시장 규모 : 용도별(2015-2020년)
  • 유럽 국가별 시장 규모
    • 유럽 시장 규모(2015-2020년)
    • 유럽 시장 규모(2021-2027년)
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아

제8장 일본

  • 일본 시장 규모의 전년대비 성장률(2015-2027년)
  • 일본의 주요 기업(2019-2020년)
  • 일본 시장 : 유형별(2015-2020년)
  • 일본 시장 규모 : 용도별(2015-2020년)

제9장 중국

  • 중국 시장 규모의 전년대비 성장률(2015-2027년)
  • 중국의 주요 기업(2019-2020년)
  • 중국 시장 : 유형별(2015-2020년)
  • 중국 시장 규모 : 용도별(2015-2020년)

제10장 동남아시아

  • 동남아시아 시장 규모의 전년대비 성장률(2015-2027년)
  • 동남아시아의 주요 기업(2019-2020년)
  • 동남아시아 시장 : 유형별(2015-2020년)
  • 동남아시아 시장 규모 : 용도별(2015-2020년)

제11장 인도

  • 인도 시장 규모의 전년대비 성장률(2015-2027년)
  • 인도의 주요 기업(2019-2020년)
  • 인도 시장 : 유형별(2015-2020년)
  • 인도 시장 규모 : 용도별(2015-2020년)

제12장 주요 기업 개요

  • Teva
  • Novartis
  • Mylan
  • Johnson &Johnson
  • Pfizer
  • Bausch Health
  • GSK
  • ChemRar Group
  • Glenmark
  • Fujifilm
  • Dr. Reddy
  • R-Pharma
  • Biovista
  • Anaxomics Biotech
  • Segue Therapeutics
  • GVK Biosciences
  • LTT Bio-Pharma
  • SOM Biotech
  • Sosei Group

제13장 애널리스트의 견해/결론

제14장 부록

LSH 21.06.10

List of Tables and Figures

  • Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2020 VS 2027
  • Table 2. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2020 VS 2027
  • Table 3. Global Drug Repositioning Market Size by Regions (US$ Million): 2020 VS 2027
  • Table 4. Global Drug Repositioning Market Size by Regions (2015-2020) & (US$ Million)
  • Table 5. Global Drug Repositioning Market Share by Regions (2015-2020)
  • Table 6. Global Drug Repositioning Forecasted Market Size by Regions (2021-2027) & (US$ Million)
  • Table 7. Global Drug Repositioning Market Share by Regions (2021-2027)
  • Table 8. Market Top Trends
  • Table 9. Key Drivers: Impact Analysis
  • Table 10. Key Challenges
  • Table 11. Global Drug Repositioning Revenue by Players (2019-2020) & (US$ Million)
  • Table 12. Global Drug Repositioning Market Share by Players (2019-2020)
  • Table 13. Ranking of Global Top Drug Repositioning Manufacturers by Revenue (US$ Million) in 2019
  • Table 14. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Repositioning as of 2020)
  • Table 15. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2019-2020)
  • Table 16. Key Players Headquarters and Area Served
  • Table 17. Key Players Drug Repositioning Product Solution and Service
  • Table 18. Founded Date of Drug Repositioning Manufacturer
  • Table 19. Mergers & Acquisitions, Expansion Plans
  • Table 20. Global Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 21. Global Drug Repositioning Revenue Market Share by Type (2015-2020)
  • Table 22. Global Drug Repositioning Forecasted Market Size by Type (2021-2027) & (US$ Million)
  • Table 23. Global Drug Repositioning Revenue Market Share by Type (2021-2027)
  • Table 24. Global Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 25. Global Drug Repositioning Revenue Market Share by Application (2015-2020)
  • Table 26. Global Drug Repositioning Forecasted Market Size by Application (2021-2027) & (US$ Million)
  • Table 27. Global Drug Repositioning Revenue Market Share by Application (2021-2027)
  • Table 28. North America Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million)
  • Table 29. North America Key Players Drug Repositioning Market Share (2019-2020)
  • Table 30. North America Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 31. North America Drug Repositioning Market Share by Type (2015-2020)
  • Table 32. North America Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 33. North America Drug Repositioning Market Share by Application (2015-2020)
  • Table 34. Europe Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million)
  • Table 35. Europe Key Players Drug Repositioning Market Share (2019-2020)
  • Table 36. Europe Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 37. Europe Drug Repositioning Market Share by Type (2015-2020)
  • Table 38. Europe Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 39. Europe Drug Repositioning Market Share by Application (2015-2020)
  • Table 40. Europe Drug Repositioning Market Size by Country (2015-2020) & (US$ Million)
  • Table 41. Europe Drug Repositioning Market Size by Country (2021-2027) & (US$ Million)
  • Table 42. Japan Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million)
  • Table 43. Japan Key Players Drug Repositioning Market Share (2019-2020)
  • Table 44. Japan Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 45. Japan Drug Repositioning Market Share by Type (2015-2020)
  • Table 46. Japan Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 47. Japan Drug Repositioning Market Share by Application (2015-2020)
  • Table 48. China Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million)
  • Table 49. China Key Players Drug Repositioning Market Share (2019-2020)
  • Table 50. China Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 51. China Drug Repositioning Market Share by Type (2015-2020)
  • Table 52. China Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 53. China Drug Repositioning Market Share by Application (2015-2020)
  • Table 54. Southeast Asia Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million)
  • Table 55. Southeast Asia Key Players Drug Repositioning Market Share (2019-2020)
  • Table 56. Southeast Asia Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 57. Southeast Asia Drug Repositioning Market Share by Type (2015-2020)
  • Table 58. Southeast Asia Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 59. Southeast Asia Drug Repositioning Market Share by Application (2015-2020)
  • Table 60. India Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million)
  • Table 61. India Key Players Drug Repositioning Market Share (2019-2020)
  • Table 62. India Drug Repositioning Market Size by Type (2015-2020) & (US$ Million)
  • Table 63. India Drug Repositioning Market Share by Type (2015-2020)
  • Table 64. India Drug Repositioning Market Size by Application (2015-2020) & (US$ Million)
  • Table 65. India Drug Repositioning Market Share by Application (2015-2020)
  • Table 66. Teva Company Details
  • Table 67. Teva Business Overview
  • Table 68. Teva Drug Repositioning Product
  • Table 69. Teva Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 70. Teva Recent Developments
  • Table 71. Novartis Company Details
  • Table 72. Novartis Business Overview
  • Table 73. Novartis Drug Repositioning Product
  • Table 74. Novartis Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 75. Novartis Recent Developments
  • Table 76. Mylan Company Details
  • Table 77. Mylan Business Overview
  • Table 78. Mylan Drug Repositioning Product
  • Table 79. Mylan Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 80. Mylan Recent Developments
  • Table 81. Johnson & Johnson Company Details
  • Table 82. Johnson & Johnson Business Overview
  • Table 83. Johnson & Johnson Drug Repositioning Product
  • Table 84. Johnson & Johnson Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 85. Johnson & Johnson Recent Developments
  • Table 86. Pfizer Company Details
  • Table 87. Pfizer Business Overview
  • Table 88. Pfizer Drug Repositioning Product
  • Table 89. Pfizer Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 90. Pfizer Recent Developments
  • Table 91. Bausch Health Company Details
  • Table 92. Bausch Health Business Overview
  • Table 93. Bausch Health Drug Repositioning Product
  • Table 94. Bausch Health Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 95. Bausch Health Recent Developments
  • Table 96. GSK Company Details
  • Table 97. GSK Business Overview
  • Table 98. GSK Drug Repositioning Product
  • Table 99. GSK Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 100. GSK Recent Developments
  • Table 101. ChemRar Group Company Details
  • Table 102. ChemRar Group Business Overview
  • Table 103. ChemRar Group Drug Repositioning Product
  • Table 104. ChemRar Group Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 105. ChemRar Group Recent Developments
  • Table 106. Glenmark Company Details
  • Table 107. Glenmark Business Overview
  • Table 108. Glenmark Drug Repositioning Product
  • Table 109. Glenmark Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 110. Glenmark Recent Developments
  • Table 111. Fujifilm Company Details
  • Table 112. Fujifilm Business Overview
  • Table 113. Fujifilm Drug Repositioning Product
  • Table 114. Fujifilm Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 115. Fujifilm Recent Developments
  • Table 116. Dr. Reddy Company Details
  • Table 117. Dr. Reddy Business Overview
  • Table 118. Dr. Reddy Drug Repositioning Product
  • Table 119. Dr. Reddy Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 120. Dr. Reddy Recent Developments
  • Table 121. R-Pharma Company Details
  • Table 122. R-Pharma Business Overview
  • Table 123. R-Pharma Drug Repositioning Product
  • Table 124. R-Pharma Revenue in Drug Repositioning Business (2019-2020) & (US$ Million)
  • Table 125. R-Pharma Recent Developments
  • Table 126. Biovista Company Details
  • Table 127. Biovista Business Overview
  • Table 128. Anaxomics Biotech Company Details
  • Table 129. Anaxomics Biotech Business Overview
  • Table 130. Segue Therapeutics Company Details
  • Table 131. Segue Therapeutics Business Overview
  • Table 132. GVK Biosciences Company Details
  • Table 133. GVK Biosciences Business Overview
  • Table 134. LTT Bio-Pharma Company Details
  • Table 135. LTT Bio-Pharma Business Overview
  • Table 136. SOM Biotech Company Details
  • Table 137. SOM Biotech Business Overview
  • Table 138. Sosei Group Company Details
  • Table 139. Sosei Group Business Overview
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Drug Repositioning Market Share by Type: 2020
  • Figure 2. Global Drug Repositioning Market Share by Type: 2027
  • Figure 3. Generic Drugs Features
  • Figure 4. Global Drug Repositioning Market Share by Application: 2020
  • Figure 5. Global Drug Repositioning Market Share by Application: 2027
  • Figure 6. Cardiovascular Diseases Case Studies
  • Figure 7. Mental Illness Case Studies
  • Figure 8. Cancer Case Studies
  • Figure 9. Drug Repositioning Report Years Considered
  • Figure 10. Global Drug Repositioning Market Size, (US$ Million), 2015 VS 2020 VS 2027
  • Figure 11. Global Drug Repositioning Market Size YoY Growth 2015-2027 (US$ Million)
  • Figure 12. Global Drug Repositioning Market Share by Regions: 2020
  • Figure 13. Global Drug Repositioning Market Share by Regions: 2027
  • Figure 14. Global Drug Repositioning Market Share by Regions (2021-2027)
  • Figure 15. China Drug Repositioning Market Share in Global Market 2015-2027
  • Figure 16. Porter's Five Forces Analysis
  • Figure 17. Global Drug Repositioning Market Share by Players in 2019
  • Figure 18. The Top 5 Players Market Share by Drug Repositioning Revenue in 2019
  • Figure 19. The Top 3 Players Market Share by Drug Repositioning Revenue in 2019
  • Figure 20. North America Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 21. Europe Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 22. Europe Drug Repositioning Market Share by Country (2015-2027)
  • Figure 23. Germany Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 24. France Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 25. U.K. Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 26. Italy Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 27. Russia Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 28. Japan Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 29. China Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 30. Southeast Asia Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 31. India Drug Repositioning Market Size YoY Growth (2015-2027) & (US$ Million)
  • Figure 32. Bottom-up and Top-down Approaches for This Report
  • Figure 33. Data Triangulation
  • Figure 34. Key Executives Interviewed

Market Analysis and Insights:

This report focuses on global and China Drug Repositioning market.

In 2020, the global Drug Repositioning market size was US$ 24958 million and it is expected to reach US$ 34602 million by the end of 2027, with a CAGR of 4.7% during 2021-2027. In China the Drug Repositioning market size is expected to grow from US$ 1769 million in 2020 to US$ 2843 million by 2027, at a CAGR of 6.86% during the forecast period.

Scope and Market Size:

Drug Repositioning market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Drug Repositioning market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2027.

By Company

  • Teva
  • Novartis
  • Mylan
  • Johnson & Johnson
  • Pfizer
  • Bausch Health
  • GSK
  • ChemRar Group
  • Glenmark
  • Fujifilm
  • Dr. Reddy
  • R-Pharma
  • Biovista
  • Anaxomics Biotech
  • Segue Therapeutics
  • GVK Biosciences
  • LTT Bio-Pharma
  • SOM Biotech
  • Sosei Group

Segment by Type

  • Generic Drugs
  • Clinical Trial Failed Drugs

Segment by Application

  • Cardiovascular Diseases
  • Mental Illness
  • Cancer
  • Other

By Region

  • North America
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Japan
  • China
  • Southeast Asia
  • India

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2020 VS 2027
    • 1.2.2 Generic Drugs
    • 1.2.3 Clinical Trial Failed Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Drug Repositioning Market Share by Application: 2020 VS 2027
    • 1.3.2 Cardiovascular Diseases
    • 1.3.3 Mental Illness
    • 1.3.4 Cancer
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Drug Repositioning Market Perspective (2015-2027)
  • 2.2 Drug Repositioning Growth Trends by Regions
    • 2.2.1 Drug Repositioning Market Size by Regions: 2015 VS 2020 VS 2027
    • 2.2.2 Drug Repositioning Historic Market Size by Regions (2015-2020)
    • 2.2.3 Drug Repositioning Forecasted Market Size by Regions (2021-2027)
    • 2.2.4 China Drug Repositioning Market Share in Global Market 2015-2027
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter's Five Forces Analysis

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top Drug Repositioning Players by Market Size
    • 3.1.1 Global Top Drug Repositioning Players by Revenue (2019-2020)
    • 3.1.2 Global Drug Repositioning Revenue Market Share by Players (2019-2020)
    • 3.1.3 Players Covered: Ranking by Drug Repositioning Revenue
    • 3.1.4 Global Drug Repositioning by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Drug Repositioning Market Concentration Ratio
    • 3.2.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 3 and Top 5 Companies by Drug Repositioning Revenue in 2019
  • 3.3 Drug Repositioning Key Players Head office and Area Served
  • 3.4 Key Players Drug Repositioning Product Solution and Service
  • 3.5 Founded Date of Drug Repositioning Manufacturer
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 DRUG REPOSITIONING BREAKDOWN DATA BY TYPE

  • 4.1 Global Drug Repositioning Historic Market Size by Type (2015-2020)
  • 4.2 Global Drug Repositioning Forecasted Market Size by Type (2021-2027)

5 DRUG REPOSITIONING BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Drug Repositioning Historic Market Size by Application (2015-2020)
  • 5.2 Global Drug Repositioning Forecasted Market Size by Application (2021-2027)

6 NORTH AMERICA

  • 6.1 North America Drug Repositioning Market Size YoY Growth 2015-2027
  • 6.2 Drug Repositioning Key Players in North America (2019-2020)
  • 6.3 North America Drug Repositioning Market Size by Type (2015-2020)
  • 6.4 North America Drug Repositioning Market Size by Application (2015-2020)

7 EUROPE

  • 7.1 Europe Drug Repositioning Market Size YoY Growth 2015-2027
  • 7.2 Drug Repositioning Key Players in Europe (2019-2020)
  • 7.3 Europe Drug Repositioning Market Size by Type (2015-2020)
  • 7.4 Europe Drug Repositioning Market Size by Application (2015-2020)
  • 7.5 Europe Drug Repositioning Market Size by Country
    • 7.5.1 Europe Drug Repositioning Market Size by Country (2015-2020)
    • 7.5.2 Europe Drug Repositioning Market Size by Country (2021-2027)
    • 7.5.3 Germany
    • 7.5.4 France
    • 7.5.5 U.K.
    • 7.5.6 Italy
    • 7.5.7 Russia

8 JAPAN

  • 8.1 Japan Drug Repositioning Market Size YoY Growth 2015-2027
  • 8.2 Drug Repositioning Key Players in Japan (2019-2020)
  • 8.3 Japan Drug Repositioning Market Size by Type (2015-2020)
  • 8.4 Japan Drug Repositioning Market Size by Application (2015-2020)

9 CHINA

  • 9.1 China Drug Repositioning Market Size YoY Growth 2015-2027
  • 9.2 Drug Repositioning Key Players in China (2019-2020)
  • 9.3 China Drug Repositioning Market Size by Type (2015-2020)
  • 9.4 China Drug Repositioning Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

  • 10.1 Southeast Asia Drug Repositioning Market Size YoY Growth 2015-2027
  • 10.2 Drug Repositioning Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Drug Repositioning Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Drug Repositioning Market Size by Application (2015-2020)

11 INDIA

  • 11.1 India Drug Repositioning Market Size YoY Growth 2015-2027
  • 11.2 Drug Repositioning Key Players in India (2019-2020)
  • 11.3 India Drug Repositioning Market Size by Type (2015-2020)
  • 11.4 India Drug Repositioning Market Size by Application (2015-2020)

12 KEY PLAYERS PROFILES

  • 12.1 Teva
    • 12.1.1 Teva Company Details
    • 12.1.2 Teva Business Overview
    • 12.1.3 Teva Drug Repositioning Introduction
    • 12.1.4 Teva Revenue in Drug Repositioning Business (2019-2020)
    • 12.1.5 Teva Recent Developments
  • 12.2 Novartis
    • 12.2.1 Novartis Company Details
    • 12.2.2 Novartis Business Overview
    • 12.2.3 Novartis Drug Repositioning Introduction
    • 12.2.4 Novartis Revenue in Drug Repositioning Business (2019-2020)
    • 12.2.5 Novartis Recent Developments
  • 12.3 Mylan
    • 12.3.1 Mylan Company Details
    • 12.3.2 Mylan Business Overview
    • 12.3.3 Mylan Drug Repositioning Introduction
    • 12.3.4 Mylan Revenue in Drug Repositioning Business (2019-2020)
    • 12.3.5 Mylan Recent Developments
  • 12.4 Johnson & Johnson
    • 12.4.1 Johnson & Johnson Company Details
    • 12.4.2 Johnson & Johnson Business Overview
    • 12.4.3 Johnson & Johnson Drug Repositioning Introduction
    • 12.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2019-2020)
    • 12.4.5 Johnson & Johnson Recent Developments
  • 12.5 Pfizer
    • 12.5.1 Pfizer Company Details
    • 12.5.2 Pfizer Business Overview
    • 12.5.3 Pfizer Drug Repositioning Introduction
    • 12.5.4 Pfizer Revenue in Drug Repositioning Business (2019-2020)
    • 12.5.5 Pfizer Recent Developments
  • 12.6 Bausch Health
    • 12.6.1 Bausch Health Company Details
    • 12.6.2 Bausch Health Business Overview
    • 12.6.3 Bausch Health Drug Repositioning Introduction
    • 12.6.4 Bausch Health Revenue in Drug Repositioning Business (2019-2020)
    • 12.6.5 Bausch Health Recent Developments
  • 12.7 GSK
    • 12.7.1 GSK Company Details
    • 12.7.2 GSK Business Overview
    • 12.7.3 GSK Drug Repositioning Introduction
    • 12.7.4 GSK Revenue in Drug Repositioning Business (2019-2020)
    • 12.7.5 GSK Recent Developments
  • 12.8 ChemRar Group
    • 12.8.1 ChemRar Group Company Details
    • 12.8.2 ChemRar Group Business Overview
    • 12.8.3 ChemRar Group Drug Repositioning Introduction
    • 12.8.4 ChemRar Group Revenue in Drug Repositioning Business (2019-2020)
    • 12.8.5 ChemRar Group Recent Developments
  • 12.9 Glenmark
    • 12.9.1 Glenmark Company Details
    • 12.9.2 Glenmark Business Overview
    • 12.9.3 Glenmark Drug Repositioning Introduction
    • 12.9.4 Glenmark Revenue in Drug Repositioning Business (2019-2020)
    • 12.9.5 Glenmark Recent Developments
  • 12.10 Fujifilm
    • 12.10.1 Fujifilm Company Details
    • 12.10.2 Fujifilm Business Overview
    • 12.10.3 Fujifilm Drug Repositioning Introduction
    • 12.10.4 Fujifilm Revenue in Drug Repositioning Business (2019-2020)
    • 12.10.5 Fujifilm Recent Developments
  • 12.11 Dr. Reddy
    • 12.11.1 Dr. Reddy Company Details
    • 12.11.2 Dr. Reddy Business Overview
    • 12.11.3 Dr. Reddy Drug Repositioning Introduction
    • 12.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2019-2020)
    • 12.11.5 Dr. Reddy Recent Developments
  • 12.12 R-Pharma
    • 12.12.1 R-Pharma Company Details
    • 12.12.2 R-Pharma Business Overview
    • 12.12.3 R-Pharma Drug Repositioning Introduction
    • 12.12.4 R-Pharma Revenue in Drug Repositioning Business (2019-2020)
    • 12.12.5 R-Pharma Recent Developments
  • 12.13 Biovista
    • 12.13.1 Biovista Company Details
    • 12.13.2 Biovista Business Overview
  • 12.14 Anaxomics Biotech
    • 12.14.1 Anaxomics Biotech Company Details
    • 12.14.2 Anaxomics Biotech Business Overview
  • 12.15 Segue Therapeutics
    • 12.15.1 Segue Therapeutics Company Details
    • 12.15.2 Segue Therapeutics Business Overview
  • 12.16 GVK Biosciences
    • 12.16.1 GVK Biosciences Company Details
    • 12.16.2 GVK Biosciences Business Overview
  • 12.17 LTT Bio-Pharma
    • 12.17.1 LTT Bio-Pharma Company Details
    • 12.17.2 LTT Bio-Pharma Business Overview
  • 12.18 SOM Biotech
    • 12.18.1 SOM Biotech Company Details
    • 12.18.2 SOM Biotech Business Overview
  • 12.19 Sosei Group
    • 12.19.1 Sosei Group Company Details
    • 12.19.2 Sosei Group Business Overview

13 ANALYST'S VIEWPOINTS/CONCLUSIONS

14 APPENDIX

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Disclaimer
  • 14.3 Author Details
Back to Top
전화 문의
F A Q